EXPLAINER

Caffeine in pregnancy: how much is safe, and why the advice disagrees

Guidelines settle on a limit near 200 mg a day — roughly two mugs of coffee. But the underlying studies are observational, and a vocal minority argues there is no clearly safe level.

Increased risk per additional 100 mg/day of caffeine in pregnancyStillbirth: 19%; Spontaneous abortion: 14%; Small for gestational age: 10%; Low birth weight: 7%0%20%40%Stillbirth19%Spontaneous abortion14%Small for gestational age10%Low birth weight7%
Increased risk per additional 100 mg/day of caffeine in pregnancy
GroupValue (%)
Stillbirth19 (5 to 35)
Spontaneous abortion14 (10 to 19)
Small for gestational age10 (6 to 14)
Low birth weight7 (1 to 12)
Increased risk per additional 100 mg/day of caffeine in pregnancy Dose–response meta-analysis of 53 cohort and case-control studies; percentage increase in risk for each extra 100 mg/day. Preterm delivery, not shown, was not significant. Source: European Journal of Epidemiology

Most obstetric guidance lands on a ceiling of about 200 mg of caffeine a day in pregnancy — roughly two mugs of instant coffee — and treats intake below that as unlikely to be a major cause of harm [s1]. That number is a reasonable rule of thumb rather than a bright line: the evidence behind it is observational, the associations grow with dose, and a minority of researchers argue there is no clearly safe threshold at all [s2][s3].

Where the 200 mg figure comes from

The American College of Obstetricians and Gynecologists set out the mainstream position in a committee opinion that remains the reference point: moderate caffeine consumption, defined as less than 200 mg per day, does not appear to be a major contributing factor in miscarriage or preterm birth [s1]. The same document is candid about the edges of that claim. The relationship of caffeine to fetal growth restriction remains undetermined, it says, and a final conclusion cannot be drawn on whether high caffeine intake is linked to miscarriage [s1]. So the reassurance is specific and hedged, not a blanket all-clear.

Caffeine reaches the fetus. It crosses the placenta, and fetal blood concentrations end up similar to the mother's, while the body's ability to clear it slows as pregnancy advances [s2]. That biology is why the question is taken seriously even where the epidemiology is messy.

The dose-response evidence

The most useful single summary is a dose-response meta-analysis of 53 cohort and case-control studies [s2]. It estimated that each additional 100 mg of caffeine a day was associated with a 14% higher risk of spontaneous abortion (95% confidence interval 10 to 19%), a 19% higher risk of stillbirth (5 to 35%), a 7% higher risk of low birth weight (1 to 12%) and a 10% higher risk of a small-for-gestational-age baby (6 to 14%) [s2]. Preterm delivery was the exception, with a non-significant 2% (−2 to 6%) [s2].

Two caveats sit alongside those numbers. The authors found no identifiable threshold below which the associations disappeared — risk rose across the usual range of intake rather than switching on at a cliff edge [s2]. But they also judged the associations generally modest within normal intake and potentially explained by study-design bias or publication bias, and concluded there was insufficient evidence to push the recommended maximum lower — while calling maintenance of current limits a wise precaution [s2].

A large UK cohort, the CARE study, put concrete odds on the growth question ACOG left open. Following 2,635 low-risk pregnancies, it found the risk of fetal growth restriction rose with caffeine: odds ratios of 1.2 (95% CI 0.9 to 1.6) at 100 to 199 mg/day, 1.5 (1.1 to 2.1) at 200 to 299 mg/day, and 1.4 (1.0 to 2.0) above 300 mg/day, all compared with under 100 mg/day, with a significant test for trend (P<0.001) [s4].

The dissent: "no safe level"

Not everyone reads this as a case for a 200 mg allowance. A narrative review screened studies across six categories of harm — miscarriage, stillbirth, low birth weight or small-for-gestational-age, preterm birth, childhood acute leukaemia, and childhood overweight — and reported that 32 of 42 sets of findings in observational studies showed significantly increased caffeine-related risk, with 14 of 17 meta-analyses in agreement for at least four outcome categories [s3]. Its author argued that current advice is not soundly based and that pregnant women should avoid caffeine [s3]. The rebuttal is the one the dose-response analysis itself raised: these are correlations, heavily exposed to confounding — for instance, nausea in healthy early pregnancy can put women off coffee, making higher intake a marker of a less robust pregnancy rather than its cause [s2].

How to read this

The honest position is that guideline advice near 200 mg a day is a pragmatic middle, not a proven safe dose [s1][s2]. The associations are real and dose-dependent but modest and confounding-prone, which is why bodies keep the limit where it is rather than either relaxing it or demanding abstinence [s2][s3]. Caffeine also hides outside coffee — in tea, cola, energy drinks, chocolate and some medicines — so tallying it is the practical difficulty, a point we cover for the general population in how much caffeine is too much.

Other everyday pregnancy exposures follow the same evidence-weighing pattern: see paracetamol in pregnancy, where the risk debate is live, and alcohol in pregnancy and FASD, where it is not. Nutrition questions in pregnancy are taken up in omega-3 and preterm birth.

This article is informational and not medical advice; caffeine intake in pregnancy should be discussed with a qualified clinician.

Sources

  1. ACOG Committee Opinion No. 462: Moderate caffeine consumption during pregnancy — Obstetrics & Gynecology (American College of Obstetricians and Gynecologists) , August 1, 2010
  2. Caffeine intake during pregnancy and adverse birth outcomes: a systematic review and dose–response meta-analysis — European Journal of Epidemiology , September 2, 2014
  3. Maternal caffeine consumption and pregnancy outcomes: a narrative review with implications for advice to mothers and mothers-to-be — BMJ Evidence-Based Medicine , August 25, 2020
  4. Maternal caffeine intake during pregnancy and risk of fetal growth restriction: a large prospective observational study — BMJ (CARE Study Group) , November 3, 2008

More on

Related coverage